PANTOFOS 20 WSP
Registered veterinary formulation (DRAP Reg: 122866)
Active: TYLOSIN AS TARTRATE---100GM; FRUCTOSE 1,6 DIPHOSPHTE-----180GM; SODIUM PHOSPHATE-----150GM; MAGNESIUM SULPHATE----100GM; AS PER INNOVATOR''S SPECIFICATION; EACH GRAM CONTAINS:-; AMOXICILLIN TRIHYDRATE 1000MG EQ.; TO AMOXICILLIN-----871.2MG; (BP VET S SPECIFICATION); EACH ML CONTAINS:-
PANTOFOS 20 WSP is a verified oral powder developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Marketed by Prix Pharmaceutica (Pvt) Ltd.
Overview
PANTOFOS 20 WSP is a verified oral powder developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Administration Route
As directed on approved label
Dosage Form
powder
Explore related Livestock solutions, our full product catalogue, and science and quality standards.
Composition
| Active Ingredient | Strength / Quantity |
|---|---|
| TYLOSIN AS TARTRATE | 100GM |
| DIPHOSPHTE | 180GM |
| SODIUM PHOSPHATE | 150GM |
| MAGNESIUM SULPHATE | 100GM |
| AMOXICILLIN TRIHYDRATE | 1000MG |
| EQ. TO AMOXICILLIN | 871.2MG |
| (BP VET S SPECIFICATION) EACH ML CONTAINS: | n/a |
Product information
Detailed product-use information is available from Prix Pharmaceutica technical support and on the approved product label.
For approved use details, please contact our technical team.
Dosage & Administration
Warnings & Precautions
For veterinary use only. Not for human use. Keep out of reach of children.
Withdrawal Period
Storage Instructions
Store below 25°C protected from direct sunlight
Packing
500GM
Target species
Livestock
Product Documents
Contact Prix Pharmaceutica (Pvt) Ltd. for approved product literature and documentation.
⚠️ Safety Notice
For veterinary use only. Use according to approved product literature and under the guidance of a qualified veterinary professional.
Need guidance?
Our technical team can assist with product selection, dosage and programme development.
Technical Support📞 +92 42 36283464Product Specifications
- Product ID
- PRX-NEW-079
- Life Stages
- Adult, Young stock
- Manufacturing
- Marketed by Prix Pharmaceutica (Pvt) Ltd.
Responsible veterinary use
Product information is provided for professional veterinary reference. Follow the approved product label and consult a qualified veterinarian where appropriate.
Frequently asked questions about PANTOFOS 20 WSP
Answers below reflect catalogue information only. Always follow the approved product label and qualified veterinary guidance.
What is PANTOFOS 20 WSP?
Which dosage form is available for PANTOFOS 20 WSP?
Which pack sizes are listed for PANTOFOS 20 WSP?
Which animal category is PANTOFOS 20 WSP listed under?
Where can product information for PANTOFOS 20 WSP be requested?
How should the approved product label be followed?
Who should be consulted before veterinary use?
Related Products
Minerals
Farvisol Bolus
Registered veterinary formulation (DRAP Reg: 075639)
Farvisol Bolus is a verified bolus developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Minerals
OXYWAY 5 INJECTION
Registered veterinary formulation (DRAP Reg: 130324)
OXYWAY 5 INJECTION is a verified injection developed and manufactured by PRIX PHARMACEUTICA PVT LTD under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Minerals
Pri-Vitoline Forte
Registered veterinary formulation (DRAP Reg: 079250)
Pri-Vitoline Forte is a verified injection developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Minerals
Pironil Plus
Registered veterinary formulation (DRAP Reg: 079254)
Pironil Plus is a verified injection developed and manufactured by Prix Pharmaceutica Pvt Ltd under strict cGMP protocols. Formulated for Livestock to provide consistent therapeutic efficacy and safety.
Related insights
- Pakistan Veterinary Pharmaceutical Industry Outlook 2027: Regulatory Modernization, Market Dynamics, and Quality Standards
- Antimicrobial Stewardship in Livestock: Responsible Antibiotic Use, AMR Risks, and Herd Health in Pakistan
- Poultry Respiratory Disease Prevention and Farm Biosecurity in Pakistan: Clinical Insights for Commercial Broilers and Layers